Study on the adoption intention of the cognitive impairment screening mini program based on TAM and TPB models
Rattachement africain : cn. Niveau de preuve : code pays fourni par la source.
Le résumé fourni par la source
With growing attention to cognitive impairment screening, digital screening tools have become an important approach for early detection and intervention. However, considerable uncertainty remains regarding users' acceptance of such mini programs, particularly among middle-aged and older adults. Based on the Technology Acceptance Model (TAM) and the Theory of Planned Behavior (TPB), this study developed an extended model to investigate the key factors influencing users' intention to adopt a cognitive impairment screening mini program. The extended model incorporated perceived usefulness (PU), perceived ease of use (PEOU), attitude (ATT), trust (TRU), subjective norm (SN), perceived behavioral control (PBC), and perceived privacy risk(PVR), and was empirically tested using structural equation model (SEM). The analysis of 610 valid questionnaires showed that PU was significantly and positively associated with ATT, while PEOU significantly and positively predicted PU. Both TRU and ATT were significantly and positively associated with users' behavioral intention (BI). In addition, SN and PBC had significant indirect effects on BI through ATT and TRU. PVR was significantly and negatively associated with both TRU and ATT, and also had a negative indirect effect on BI. These findings offer practical implications for the design, privacy management, and promotion of digital health tools, particularly the cognitive impairment screening mini programs.
Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.
Le contrôle bibliographique ouvert
DOI retrouvé dans Crossref DOI retrouvé ; titre concordant.
- Titre Crossref
- Study on the adoption intention of the cognitive impairment screening mini program based on TAM and TPB models
- Date Crossref
- 27/06/2026
- Éditeur
- Springer Science and Business Media LLC
- Type
- journal-article
Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude, et il ne compte pas comme une seconde source scientifique indépendante.
Où se fait cette recherche
-
Dalian Medical University National-Local Joint Engineering Research Center for Drug-Research and Development(R&D) of Neurodegenerative Disease pays non établi dans la noticeUniversité ou école supérieure
-
Second Affiliated Hospital of Dalian Medical University pays non établi dans la noticeÉtablissement de santé
-
First Affiliated Hospital of Dalian Medical University pays non établi dans la noticeÉtablissement de santé
-
Ltd Shanghai Bofang Medical Technology Co. pays non établi dans la noticeEntreprise
National-Local Joint Engineering Research Center for Drug-Research and Development(R&D) of Neurodegenerative Disease — Dalian Medical University, Second Affiliated Hospital of Dalian Medical University et First Affiliated Hospital of Dalian Medical University, avec 1 autre affiliation.
Une affiliation ne permet pas de déduire la nationalité d’un auteur.